AU7693600A - Dna construct and its use - Google Patents
Dna construct and its use Download PDFInfo
- Publication number
- AU7693600A AU7693600A AU76936/00A AU7693600A AU7693600A AU 7693600 A AU7693600 A AU 7693600A AU 76936/00 A AU76936/00 A AU 76936/00A AU 7693600 A AU7693600 A AU 7693600A AU 7693600 A AU7693600 A AU 7693600A
- Authority
- AU
- Australia
- Prior art keywords
- xanthophyll
- oilseed plant
- dna construct
- nucleotide sequence
- carotene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
WU U1/zUUll C1/SEUU/U1767 1 DNA construct and its use. The present invention relates to a new DNA construct for transformation into oilseed plants. The DNA construct comprises nucleotide sequences encoding peptides with enzyme 5 activities necessary for the high-level production and esterification of keto group-containing xanthophylls in oilseed plants. Background of the invention Carotenoids are produced de novo by plants, fungi, algae and some bacteria. A number of biosynthetic steps are needed for the biological production of the carotenoids. 10 There are two chemically different groups of carotenoids, namely carotenes containing only carbon and hydrogen molecules and xanthophylls containing oxygen in the molecule in addition to carbon and hydrogen. The xanthophylls, and particularly astaxanthin (3,3'-dihydroxy-P-P-carotene-4,4' dione), are often colored pigments and are used as such or as anti-oxidants. 15 Carotenes are biological precursors for the production of the oxygen-containing xanthophylls. There are two types of enzymes responsible for the introduction of hydroxy groups and keto groups into the carotenes, namely hydroxylases and ketolases, respectively. The keto group-containing xanthophyll astaxanthin, which has keto and hydroxy groups, is biosynthetically produced from beta-carotene. 20 Large-scale production of xanthophylles from natural sources is at present performed by AstaCarotene AB, Gustavsberg, Sweden, by cultivation of the alga Haematococcus pluvialis for the production of astaxanthin in esterified form. It would be desirable to be able to produce keto group-containing xanthophylls particularly astaxanthin, in oilseed plants. Oilseed plants have naturally p-carotene 25 hydroxylases but lack p-carotene C-4-oxygenase enzymes or ketolases. Description of the invention The present invention provides DNA constructs enabling and promoting production of keto group containing xanthophylls, especially astaxanthin, in oilseed plants, such as rape, sunflower, soybean and mustard. The DNA construct is transformed into the 30 oilseed plant cell for expression of a protein or fused protein which has an enzyme activity enabling keto group insertion into a carotene or hydroxy carotene for the biosynthetic production of a keto group containing xanthophyll, such as cantaxanthin (p,p-carotene-4,4' dione) and/or astaxanthin. Use is thus made of the biosynthetic pathway of the oilseed plant to WU UI/LUUII PCT/SEUU/U1767 2 produce carotenoids. The naturally occurring synthesis of carotenoids involves a number of enzymes, namely 1 -D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta 5 cyclase, p-carotene hydroxylase, and P-carotene C-4-oxygenase. Genes coding for peptides having these enzymatic activities may be inserted into the DNA construct of the invention, one or several per construct, to promote high-level production in the transgenic oilseed plant. In case only one enzyme coding gene is inserted per plant, two or more plants may be sexually interbred to produce plants containing all the desired enzyme activities. 10 Thus, the present invention is directed to a DNA construct comprising in the 5' to 3' direction of transcription operably linked a promoter region directing transcription to the seed of an oilseed plant, a nucleotide sequence coding for at least one peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification in an oilseed plant and a transcriptional termination region. 15 In a preferred embodiment of the invention the DNA construct additionally comprises between the promoter region and the nucleotide sequence coding for at least one peptide with enzyme activity a nucleotide sequence coding for a transit peptide directing the translated fusion polypeptide to the chloroplast of the oilseed plant. The DNA construct is preferably such that the promoter is a napin promoter, the 20 peptide with enzyme activity necessary for keto group containing xanthophyll production is selected from the group consisting of peptides with 1-D-deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta-cyclase, p-carotene hydroxylase, and p-carotene C-4-oxygenase activity. To 25 promote esterification of astaxanthin a nucleotide sequence coding for a peptide with acyl transferase activity may be included in the group. In a preferred embodiment of the DNA construct according to the invention the nucleotide sequence coding for a peptide with enzyme activity is a nucleotide sequence coding for a N-terminally truncated p-carotene C-4-oxygenase gene from the alga 30 Haematococcus pluvialis. An example of the DNA construct of the invention is presented in the sequence listing as SEQ ID NO:1 and in Fig.1.
WO 01/20011 PCT/SEUU/U1767 3 The present invention is also directed to a transgenic oilseed plant cell comprising the DNA construct of the invention, and preferably the oilseed plant is selected from the group consisting of rape, sunflower, soybean and mustard. The invention is additionally directed to transgenic oilseed plant-produced 5 xanthophyll, e.g. canthaxanthin and astaxanthin. A preferred aspect of the invention is directed to transgenic oilseed plant produced astaxanthin esters. The present invention will now be illustrated with reference to the DNA construct disclosed in the sequence listing and in Fig.1, and the following description of 10 embodiments. However, the invention is not limited to these exemplifications. Short description of the drawings Fig. 1 illustrates the nucleotide sequence of the DNA construct comprising the napin promoter, the chloroplast localization signal, the N-terminally truncated P-carotene C-4-oxygenase gene and the termination sequence, and the deduced amino acid sequences of the transit peptide 15 and the p-carotene C-4-oxygenase. Description of embodiments The invention is illustrated by production of astaxanthin in the seed of oilseed rape. The astaxanthin produced in the seed of the transgenic plant is extracted as part of the extracted oil. By use of conventionally used protocols for Agrobacterium tumefaciens 20 mediated transformation such as described by (Hoekema et al.1983, An et al. 1986, Fry et al. 1987, DeBlock et al. 1988, Radke et al.1988, or Moloney et al. 1989) transgenic plants are produced having a chimeric DNA construct that is genetically inherited and is able to produce astaxanthin. The nucleotide sequence of the chimeric DNA construct consist of four parts of different genetic origin namely: (1) a promoter, (2) a localization signal, (3) a p-carotene C-4 25 oxygenase coding region and (4) a termination sequence. The napin promoter directs transcription to the seed of oilseed rape (Stilberg et al 1996). This promoter was coupled to a localization signal similar but not identical to a transit peptide (TP) of Rbcsla (Krebbers, 1988) that directs the translated product of a fused gene to the chloroplast. The promoter and the TP sequence were ligated to a part of the coding 30 sequence of a ketolase gene BCK (Kajiwara et al. 1995). This enzyme oxygenates p-carotene to canthaxanthin, (Fraser et al. 1997). The chimeric DNA construct was then coupled to a suitable termination sequence, e.g. that of the Agrobacterium tumefaciens nopaline synthase gene (the nos 3' end)(Bevan et al. 1983), as illustrated in Fig.1.
WU UI/ZUUII PCT/SEOO/01767 4 Cellular storage of Astaxantin The storage of large amounts of free astaxanthin in plants will be difficult due to toxic effects of the molecule as it intercalates in the plant membranes. An effective esterification of astaxanthin to fatty acids enables storage of the esterified molecules in 5 triacylglycerol containing oleosomes. Thus, an acyl transferase can be claimed to be of fundamental importance for the process, as is proteins that can mediate transport of different forms of astaxanthin from the chloroplast to the vesicles. Sequences and oligonucleotides used in the construction of the DNA construct 1. Napin promoter (GeneBank ACCESSION No. J02798) 10 This promoter sequence, a 1145 base pair fragment including the 5' leader sequence has a unique HindIII site at the 5' end. The 3' end was synthesized with an additionally 6 nucleotide BamHI site. 2. Transit peptide similar to RBCSla (GeneBank A CCESSION No. X13611, X14565) The transit peptide (TP) was amplified by PCR from -28 to the end of the transit 15 cleavage aa=54/55 site of the Rbcsla gene. The 5' end was synthesized with a BamHI site and similarly the 3' sequence was synthesized with a XbaI site. The two following oligonucleotides were used for the PCR amplification. BamHI 20 5' primer: TP1 5'AGAC GGATCC TCAGTCACACAAAGAGTA 3' SacI XbaI 3' primer: TP2 5'GTTC GAGCTC TCTAGA CATGCAGTTAACGC 3' 3. BCK (&carotene C-4 oxygenase) (Genebank A CCESSION No. D45881) 25 The BCK fragment was amplified by PCR including a 5' XbaI site and was ligated to the TP already described. The 5' primer (BCK1) used for PCR, is homologous to the BCK sequence from nucleotide 264 and the 3' oligonucleotide (Ax40) ends with a stop codon and was synthesized with a SacI restriction site for cloning. The synthesized fragment was fused to the TP as shown in Fig 1. 30 Oligonucleotides used for PCR: XbaI 5' primer: BCK1 5'ACAG TCTAGA ATGCCATCCGAGTCGTCA 3' SacI 3'primer: AX40 5'CACCGAGCTCCATGACACTCTTGTGCAGA 3' WO 01/20U11 PCT/SE00/01767 5 Description of SEQ ID NO:1 and SEQ ID NO:2 The sequences shown i Fig. 1 are the same as the two sequences which are shown in the sequence listing. The SEQ ID NO:1 is a nucleotide sequence composed of the following features: 5 Nucleotide No. Cloning site HindIII 1-6 Napin Promoter 1-1145 Cloning site BamHI 1146-1151 Transit peptide leader 1152-1178 10 Transit peptide coding 1179-1347 Cloning site XbaI 1348-1353 p-carotene C-4-oxygenase 1354-2217 p-carotene C-4-oxygense 3' untranslated 2218-2266 Cloning site SacI 2267-2272 15 Nopaline synthetase termination 2273-2536 Cloning site EcoRI 2538-2543 The SEQ ID NO: 2 is a deduced amino acid sequence of the fusion protein of the transit peptide and the peptide with p-carotene C-4-oxygenase activity.
WU UI/2UUlI I Iu/5iEUU/Ui7O7 6 References An G, Watson BD, Chiang CC (1986), Transformation of tobacco, tomato, potato and 5 Arabidopsis-thaliana using a binary vector system. Plant Physiology 81 (1) 301-305. Bevan M, BarnesWM and Chilton MD (1983). Structure and transcription of the nopaline synthase gene region of T-DNA. Nucleic Acids Res. 11 (2), 369-385 . 10 DeBlock M, DeBrouwer D, Tenning P (1989). Transformation of Brassica napus and Brassica oleracea using Agrobacterium tumefaciens and the expression of the BAR and NEO genes in transgenic plants Plant Physiology 91:2, 694-701. Fraser PD, Miura Y, Misawa N, (1997). In vitro characterization of astaxanthin biosynthetic 15 enzymes. J Biol Chem. Mar 7;272(10):6128-35. Fry J, Barnason A, and Horsch RB, (1987). Transformation of Brassica napus with Agrobacteriium tumefaciens based vectors. Plant Cell Reports 6:321-325. 20 Hoekema A, Hirsch PR, Hooykas PJJ Schilperoort, (1983). A binary vector strategy based on separation of vir and T-region of the Agrobacterium tumefaciens Ti-plasmid. Nature vol 303, 179-180. Josefsson LG, Lenman M, Ericson ML and Rask L, (1987). Structure of a gene encoding the 25 1.7 S storage protein, napin, from Brassica napus. J. Biol. Chem. 262 (25), 12196-12201. Kajiwara S, KakizonoT, Saito T, Kondo K, OhtaniT, Nishio N, Nagai S and Misawa N. (1995). Isolation and functional identification of a novel cDNA for astaxanthin biosynthesis from Haematococcus pluvialis, and astaxanthin synthesis in Escherichia coli Plant Mol. Biol. 30 29 (2), 343-352.
WO 01/20011 PCT/SEUU/U1767 7 Krebbers E, Seurinck J, Herdies L, Cashmore AR and Timko MP, (1988). Four genes in two diverged subfamilies encode the rubulose-1, 5-bisphosphate carboxylase small subunit polypeptides of Arabidopsis thaliana Plant Mol. Biol. 11, 745-759. 5 Moloney M, Walker JM and Sharma KK, (1989). High efficiency transformation of Brassica napus using Agrobacterium vectors. Plant Cell Reports 8:238-242. Radke SE, Andrews BM, Moloney MM, Crouch ML, Kridl JC, Knauf VC (1988), Transformation of Brassica napus using Agrobacterium tumefaciens - Developmentally 10 regulated Expression of a reintroduced napin gene. TAG, 75: (5) 685-694 . Pua E-C, Mehra-Palta A, Nagy F and Chua N-H, (1987). Transgenic plants of Brassica napus. Biotechnology vol 5, 815-817. 15 Stilberg K, Ellerst6m M, Ezcurra I, Ablov S, Rask L (1996). Disruption of an overlapping E box/ABRE motif abolished high transcription of the napA storage-protein promoter in transgenic Brassica napus seeds. Planta 199(4):515-9.
Claims (11)
1. A DNA construct comprising in the 5' to 3' direction of transcription operably linked a promoter region directing transcription to the seed of an oilseed plant, a nucleotide sequence coding for at least one peptide with enzyme activity necessary for keto group 5 containing xanthophyll production and esterification in an oilseed plant and a transcriptional termination region.
2. The DNA construct according to claim 1, which between the promoter region and the nucleotide sequence coding for at least one peptide with enzyme activity additionally comprises a nucleotide sequence coding for a transit peptide directing the translated fusion 10 polypeptide to the chloroplast of the oilseed plant.
3. The DNA construct according to claim 1 or 2, wherein the promoter is a napin promoter, the peptide with enzyme activity necessary for keto group containing xanthophyll production and esterification is selected from the group consisting of peptides with, 1-D deoxyxylulose 5-phosphate synthase, isopentenyl pyrophosphate:dimethylallyl pyrophosphate 15 isomerase, geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, zeta-carotene desaturase, lycopene beta-cyclase, p-carotene hydroxylase, P-carotene C-4 oxygenase, and acyl transferase activity.
4. The DNA construct according to any one of claims 1 - 3, wherein the nucleotide sequence coding for a peptide with enzyme activity is a nucleotide sequence 20 coding for a N-terminally truncated p-carotene C-4-oxygenase gene from the alga Haematococcus pluvialis.
5. The DNA construct according to claim 4, wherein the nucleotide sequence is SEQ ID NO:1.
6. Transgenic oilseed plant cell comprising the DNA construct of any one of 25 claims 1-5 .
7. Transgenic oilseed plant cell according to claim 6, wherein the oilseed plant is selected from the group consisting of rape, sunflower, soybean and mustard.
8. Transgenic oilseed plant-produced xanthophyll.
9. Transgenic oilseed plant-produced xanthophyll according to claim 8, wherein 30 the xanthophyll is canthaxanthin
10. Transgenic oilseed plant-produced xanthophyll according to claim 8, wherein the xanthophyll is astaxanthin.
11. Transgenic oilseed plant-produced xanthophyll according to claim 8, wherein the xanthophyll is astaxanthin esters.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9903336A SE9903336D0 (en) | 1999-09-17 | 1999-09-17 | DNA construct and its use |
SE9903336 | 1999-09-17 | ||
PCT/SE2000/001767 WO2001020011A1 (en) | 1999-09-17 | 2000-09-13 | Dna construct and its use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7693600A true AU7693600A (en) | 2001-04-17 |
Family
ID=20417035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU76936/00A Abandoned AU7693600A (en) | 1999-09-17 | 2000-09-13 | Dna construct and its use |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1212444A1 (en) |
JP (1) | JP2003509057A (en) |
AU (1) | AU7693600A (en) |
CA (1) | CA2382444A1 (en) |
NO (1) | NO20021305L (en) |
SE (1) | SE9903336D0 (en) |
WO (1) | WO2001020011A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2418155A1 (en) | 2000-07-18 | 2002-01-24 | National Research Council Of Canada | Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
US20070094749A1 (en) | 2002-08-20 | 2007-04-26 | Sungene Gmbh & Co. Kgaa | Method for producing ketocarotinoids in plant fruit |
DE10321963A1 (en) * | 2003-05-15 | 2004-12-02 | Icon Genetics Ag | Process for the production of a plastid-directed protein in plant cells |
EP1866428A2 (en) | 2005-03-18 | 2007-12-19 | Microbia, Inc. | Production of carotenoids in oleaginous yeast and fungi |
US20070293568A1 (en) | 2006-06-16 | 2007-12-20 | Yamaha Hatsudoki Kabushiki Kaisha | Neurocyte Protective Agent |
US8691555B2 (en) | 2006-09-28 | 2014-04-08 | Dsm Ip Assests B.V. | Production of carotenoids in oleaginous yeast and fungi |
CA2767724A1 (en) | 2009-07-23 | 2011-01-27 | Chromatin, Inc. | Sorghum centromere sequences and minichromosomes |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618988A (en) * | 1990-03-02 | 1997-04-08 | Amoco Corporation | Enhanced carotenoid accumulation in storage organs of genetically engineered plants |
US5916791A (en) * | 1995-11-24 | 1999-06-29 | Hirschberg; Joseph | Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β--C--4--oxygenase activity for biotechnological production of (3S,3S)astaxanthin |
BR9713462A (en) * | 1996-08-09 | 2000-03-28 | Calgene Inc | Methods for producing carotenoid compounds and special oils in plant seeds. |
US6429356B1 (en) * | 1996-08-09 | 2002-08-06 | Calgene Llc | Methods for producing carotenoid compounds, and specialty oils in plant seeds |
SE522246C2 (en) * | 1997-02-27 | 2004-01-27 | Astacarotene Ab | Oral preparation for prophylactic and therapeutic treatment of Helicobacter Sp. infection |
SE511237C2 (en) * | 1997-12-16 | 1999-08-30 | Astacarotene Ab | Use of at least one type of xanthophyll for the preparation of a human or veterinary drug for the prophylactic treatment of mastitis in mammalian mothers |
-
1999
- 1999-09-17 SE SE9903336A patent/SE9903336D0/en unknown
-
2000
- 2000-09-13 AU AU76936/00A patent/AU7693600A/en not_active Abandoned
- 2000-09-13 EP EP00966616A patent/EP1212444A1/en not_active Withdrawn
- 2000-09-13 WO PCT/SE2000/001767 patent/WO2001020011A1/en not_active Application Discontinuation
- 2000-09-13 JP JP2001523782A patent/JP2003509057A/en active Pending
- 2000-09-13 CA CA002382444A patent/CA2382444A1/en not_active Abandoned
-
2002
- 2002-03-15 NO NO20021305A patent/NO20021305L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20021305D0 (en) | 2002-03-15 |
NO20021305L (en) | 2002-05-15 |
CA2382444A1 (en) | 2001-03-22 |
SE9903336D0 (en) | 1999-09-17 |
EP1212444A1 (en) | 2002-06-12 |
WO2001020011A1 (en) | 2001-03-22 |
JP2003509057A (en) | 2003-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sandmann | Carotenoid biosynthesis and biotechnological application | |
EP1549133B1 (en) | Fatty acid desaturases from fungi | |
US5618988A (en) | Enhanced carotenoid accumulation in storage organs of genetically engineered plants | |
US6787683B1 (en) | Phytyl/prenyltransferase nucleic acids, polypeptides and uses thereof | |
EP1709179B1 (en) | Transgenic plants with reduced level of saturated fatty acid and methods for making them | |
EP0746615B1 (en) | Dna constructs, cells and plants derived therefrom | |
JP2004514401A (en) | Transgenic plants containing tocopherol methyltransferase | |
CA2491234A1 (en) | Use of a gene for increasing the oil content in plants | |
US8557585B2 (en) | Fusion polynucleotide for biosynthesis of beta-carotene using bicistronic gene expression and method for producing beta-carotene using the same | |
US20150322444A1 (en) | Enhanced accumulation of carotenoids in plants | |
AU7693600A (en) | Dna construct and its use | |
KR100905219B1 (en) | Fusion polynucleotide for biosynthesis of beta-carotene comprising self-cleavage 2A sequence and transformed cell using the same | |
JP3759628B2 (en) | Production of bleaching herbicide-tolerant plants | |
Karim Zarhloul et al. | Breeding high-stearic oilseed rape (Brassica napus) with high-and low-erucic background using optimised promoter-gene constructs | |
CA2423502A1 (en) | Triacylglycerol lipases from arabidopsis thaliana | |
EP1458878A1 (en) | Method of increasing the transgene-coded biomolecule content in organisms | |
Supathaweewat et al. | cDNA cloning and expression analyses of phytoene synthase 1, phytoene desaturase and ζ-carotene desaturase genes from Solanum lycopersicum KKU-T34003. | |
ZA200409749B (en) | Fatty acid desaturases for fungi |